Mediators Affecting IL2 Function in Burn Immunosuppression

  • B. G. Sparkes
  • J. A. Teodorczyk-Injeyan
  • W. J. Peters
  • R. E. Falk
Conference paper
Part of the NATO ASI Series book series (NSSA, volume 139)


Thermal injury induces the most complex array of physiological dysfunction known. Extensive research effort has led to an understanding of some of the changes occurring following a major burn, yet early pathological changes have been documented to be different from those of later phases and great difficulties have arisen in determining cause-and-effect relationships in these changes. For example, intensive first treatment using specific, systemic and local therapy successfully delays mortality in the early phase of very severe burns but has little relationship to the outcome. This was observed where burn victims, treated early, survived initially in greater numbers than those devoid of early treatment (48% greater at day 4, 32% at day 12), whereas the difference was only 7.3% at 2 months1. The fatal outcome of the late phase is ascribed to multiple organ system failure (MOSF) but not always to concomitant sepsis, for often bacteria cannot be detected in up to half the patients who die2.Where sepsis had been well controlled and was not confirmed at death, it had been surmised that infection was not the primary cause of death. In this situation, devitalized tissue and/or circulating endotoxin have been thought to perpetuate some mediator-induced response which lead to MOSF2. Evidence in animal models suggests, however, that endotoxic shock and burn shock are two different pathologies. Whereas endotoxin mediates its effects through lipid peroxidation via the production of oxygen free radicals, and catalase and superoxide dismutase can reverse these effects, burn shock is not protected by these enzymes3. Thus endotoxin, when present, may not be the main mediator of late death in burns.


Peripheral Blood Mononuclear Cell Thermal Injury Mixed Lymphocyte Reaction Multiple Organ System Failure Normal Peripheral Blood Mononuclear Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    G. Arturson. The Los Alfaques disaster: a boiling liquid, expanding-vapour explosion. Burns 7: 233–251 (1980).CrossRefGoogle Scholar
  2. [2]
    R. H. Demling. Burns. New Eng. J. Med. 313: 1389–1398 (1985).CrossRefGoogle Scholar
  3. [3]
    T. Yoshikawa, N. Yoshida, H. Miyagawa, T. Takemura, T. Tanigawa, M. Murakami and M. Kondo. Role of free radical lipid peroxidation in burn and endotoxin shock. These Proceedings.Google Scholar
  4. [4]
    J. M. Heibert, M. McGough, G. Rodeheaver. The influence of catabolism on immunocompetence in burned patients. Surgery: 86: 242–247 (1979).Google Scholar
  5. [5]
    C. L. Miller, C. C. Baker. Changes in lymphocyte activity after thermal injury. J. Clin. Invest. 63: 202–210 (1979).PubMedCrossRefGoogle Scholar
  6. [6]
    J. H. N. Wolfe, I. Saporoschetz, A. E. Young, N. E. O’Connor and J. A. Mannick. Suppressive serum, suppressor lymphocytes and death from burns. Ann. Surg. 193: 513–520 (1981).PubMedGoogle Scholar
  7. [7]
    J. L. Ninneman, A. E. Stockland, J. T. Condie. Induction of prostaglandin synthesis-dependent suppressor cells with endotoxin: Occurrence in patients with thermal injuries. J. Clin. Immunol. 3: 142–150 (1983).CrossRefGoogle Scholar
  8. [8]
    J. L. Ninneman. Immunosuppression following thermal injury through B cell activation of suppressor T cells. J. Trauma 20: 206–213 (1980).CrossRefGoogle Scholar
  9. [9]
    S. Chouaib, L. Chatenoud, D. Klatzmann and D. Fradelizi. The mechanisms of inhibition of human IL 2 production. II PGE2 induction of suppressor T lymphocytes. J. Immunol 132: 1851–1857 (1984). PubMedGoogle Scholar
  10. [10]
    J. A. Mannick, M. L. Rodrick. Cellular immune function and injury. These Proceedings.Google Scholar
  11. [11]
    A. C. Antonacci, S. E. Calvano, L. E. Reaves, A. Prajapati, R. Bockman, K. Welte, R. Mertelsmann, S. Gupta, R. A. Good and G. T. Shires. Autologous and allogeneic mixed-lymphocyte responses following thermal injury in man: The immunomodulatory effects of interleukin 1, interleukin 2 and a prostaglandin inhibitor, WY-18251. Clin. Immunol. & Immunopath. 30: 304–320 (1984).CrossRefGoogle Scholar
  12. [12]
    M. Braquet, P. Lavaud, D. Dormont, R. Garay, R. Ducousso, J. Guilbaud, M. Chignard, P. Borgeat and P. Braquet. Leukocytic functions in burn- injured patients. Prostaglandins 29: 747–764 (1985).PubMedCrossRefGoogle Scholar
  13. [13]
    J. A. Teodorczyk-Injeyan, B. G. Sparkes, W. J. Peters and R. E. Falk. Lymphoproliferative response to phytohemagglutinin in the burn patient - no paradigm in vitro. J. Burn Care Rehab. 7: 112–116 (1986).CrossRefGoogle Scholar
  14. [14]
    B. G. Sparkes, J. A. Teodorczyk-Injeyan, W. J. Peters and R. E. Falk. Polyclonal antibody production in the burn patient - kinetics and correlation with T cell activity. Proc. Can. Fed. Bio. Soc. 28: 131 (1985).Google Scholar
  15. [15]
    J. A. Teodorczyk-Injeyan, B. G. Sparkes, W. J. Peters and R. E. Falk. Polyclonal immunoglobulin production in the burned patient - kinetics and correlation with T cell activity. J. Trauma 26 (9): - (1986).Google Scholar
  16. [16]
    J. A. Teodorczyk-Injeyan, B. G. Sparkes, W. J. Peters and R. E. Falk. Inhi- biton of T cell activation in burn patients during post-burn immunosuppression. Eur. Soc. Sura. Res. 17 (SI): 27 (1985). Google Scholar
  17. [17]
    J. A. Teodorczyk-Injeyan, B. G. Sparkes, G. B. Mills, W. J. Peters and R. E. Falk. Impairment of T cell Activation in burn patients: a possible mechanism of thermal injury-induced immunosuppression. Clin. Exv. Immunol. 65 (2): - (1986).Google Scholar
  18. [18]
    J. A. Teodorczyk-Injeyan, B. G. Sparkes, G. B. Mills, W. J. Peters and R. E. Falk. Impaired expression of interleukin-2 receptor (IL 2R) in the immu- nosuppressed burn patient: Reversal by exogenous IL 2. J. Trauma 27 (1): - (1987).Google Scholar
  19. [19]
    G. A. Schoenenberger. Klinik und Forschung bei schweren Verbrennungen. Schweiz Rdsch. Med. PRAXIS 67 (32): 1163–1174 (1978).Google Scholar
  20. [20]
    J. A. Ninneman and M. D. Stein. Suppression of in vitro lymphocyte response by “burn toxin”—isolates from thermally injured skin. Immunol. Lett. 2: 339–342 (1981).CrossRefGoogle Scholar
  21. [21]
    G. A. Schoenenberger. Burn toxins isolated from mouse and human skin. Their characterization and immunotherapy effects. Monogr. Allergy, 9: 72–139 (1975).Google Scholar
  22. [22]
    R. M. Gorczynski, J. Rogers and J. J. Harris (1985). Inhibition of human natural killer (NK) mediated lysis of K562 with purified defined carbohydrates and monoclonal antibodies. In Genetic control of host resistance to infection and malignancy. p769–774. E. Skamene & P. Kongshaven Eds. Alan R. Liss Inc., Montreal.Google Scholar
  23. [23]
    P. H. Hasler, M. Allgower and G. A. Schoenenberger. Immunoradiometric assay (IRMA) for quantitative determination of a cutaneous human burn toxin in plasma of severely burnt patients. Eur. Soc. Surg. Res. 16 (S1):107–108 (1984). Google Scholar
  24. [24]
    M. Braquet. Impaired host defence mechanisms in burn and sepsis. These proceedings.Google Scholar
  25. [25]
    J. L. Ninneman. Immmune depression and sepsis following injury: the role of circulating mediators. These Proceedings.Google Scholar
  26. [26]
    C. R. Baxter. Polymorphonuclear leukocyte function in the immune response in burns. These Proceedings.Google Scholar
  27. [27]
    B. G. Sparkes, P. H. Hasler, M. Allgower and G. A. Schoenenberger. Unpublished data.Google Scholar
  28. [28]
    M. Allgower, M. Graf, P. Hasler, B. Kistler, B. Kremer and G. A. Schoenenberger. Evidence of possible involvement of a cutaneous burn toxin in the late burn disease/mortality. Bull & Clin. Rev. Burn Inj. 1 (3):27–29 (1984).Google Scholar
  29. [29]
    J. L. Ninneman. Frontiers in understanding burn injury. J. Trauma 24 (9):S 81 – S 83 (1984).Google Scholar
  30. [30]
    C. Echinard, D. Bernard, C. Vescovali and J. P. Jouglard. Kinetics of immune depression in burned rats: the sixth day phenomenon. J. Burn Care 6 Rehab. 6 (3):256–260 (1985).CrossRefGoogle Scholar
  31. [31]
    J. F. Hansbrough, V. Peterson, E. Kortz and J. Piacentine. Post burn immunosuppression in an animal model: monocyte dysfunction induced by burned tissue. Surgery 93 (3):415–423 (1983).PubMedGoogle Scholar
  32. [32]
    R. L. Edelson and J. M. Fink. The immunologic function of skin. Scientific American 252 (6):46–53 (1985).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • B. G. Sparkes
    • 1
  • J. A. Teodorczyk-Injeyan
    • 2
  • W. J. Peters
    • 3
  • R. E. Falk
    • 2
  1. 1.The Defence & Civil Institute of Environmental Medicine DownsviewOntarioCanada
  2. 2.Department of SurgeryUniversity of TorontoCanada
  3. 3.The Ross Tilley Burn CentreWellesley HospitalTorontoCanada

Personalised recommendations